Sir, we read with an interest the article by Loncar on the study cohort of 15 women with embryo abnormalities, the author correlates ultrasound placenta examination and pathohistological fi ndings in placenta with different kinds of embryo abnormalities. Two main ultrasound placenta fi ndings of those patients were hydrops placenta and cystic placenta degeneration.
To the Editor Sir, we read with an interest the article by Loncar on the study cohort of 15 women with embryo abnormalities, the author correlates ultrasound placenta examination and pathohistological fi ndings in placenta with different kinds of embryo abnormalities. Two main ultrasound placenta fi ndings of those patients were hydrops placenta and cystic placenta degeneration.
With no doubts, ultrasound examination is the most comfort, but limited. For explanation, a powerful methodology of pathohistology and immunohistochemistry is excellent for describing changes of protein levels in terms correlated to tissue structure. There is a relatively new method dealing with visualisation of whole protein body of the tissue -2-D electrophoretic protein separation. The proteome (= the entire set of proteins expressed by tissue) is divided according to Mr and pI of individual proteins and changes in level of every particular protein can be checked in one gel.
With consideration of the above-mentioned paper of Loncar, we introduce the fi rst glance at differences in smokers and nonsmokers placental proteome in term. Placentas and foetuses of smoking pregnant women also exhibit a broad range of abnormalities, some of them described in the work by Loncar. Although smoker placentas show no increased incidence of necrosis, there are detectable microscopic lesions refl ecting a periodic low perfusion. Those lesions typically include obliterative endarteritis, slight cytotrophoblast hyperplasia, stromal fi brosis, and small villous infarcts. The most frequent lesions in smoker placenta are degeneration of the cytotrophoblast, cytotrophoblast hyperplasia, focal syncytial necrosis, reduced number of vasculo-syncytial membranes, irregular thickness of the basement membrane, and increased collagen content in the villous stroma. Smoking during pregnancy also signifi cantly increases villus surface and their calcifi cation.
We present here the fi rst visualisation of whole placenta proteome of non-smokers (n=5) and smokers (n=5) at term.
The proteome of 5 pooled samples of non-smoker and smoker placentas were compared. Firstly, we established the proteome map of normal human placenta as a standard for further proteomic analyses. The spots on 2-D gels were visualized by SPYRO-Ruby staining in the 4-7 pI range. About 400 distinct spots were detected in stained gels. Analysis of stained gels between the two groups revealed 19 spots with up or down changed expression. Expression of 11 spots was up-regulated in placentae of smoking women, 8 protein spots were down-regulated in them. Changes in expression of 4 spots were statistically signifi cant.
Generation of placental proteome maps struggles with counterbalancing resolution of the maps and maps background to gain the best results. Finally, we performed 2-DGE with extraction protocol based on dichlormethane/methanol sample precipitation and 7M urea/2M thiourea/CHAPS solubilisation. Our work, performed on complex samples of total placental stromal tissue, revealed changes in expression of 19 placental proteins. We suppose that differentially expressed protein may belong to different functional protein classes.
Chronic hypoxia in smokers leads to changes in expression of many regulatory proteins, thus also affecting placental angiogenesis. Compensatory angiogensis resulting from adaptation to hypoxic stress can serve as protective phenomenon in smoking women against preeclampsia.
